NIKKEI 225
39,346.92 +559.54 (+1.44%) HANG SENG
19,642.20 +88.59 (+0.45%) CRUDE OIL
80.02 -0.04 (-0.05%) GOLD FUTURES
2,440.50 +23.10 (+0.96%) DOW
40,003.59 +134.19 (+0.34%) Bitcoin GBP
52,482.97 -382.39 (-0.72%)
VSE Corporation (VS3.F)
| Previous close | 72.50 |
| Open | 69.50 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 69.50 - 69.50 |
| 52-week range | 43.60 - 79.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 1.278B |
| Beta (5Y monthly) | 1.67 |
| PE ratio (TTM) | 23.72 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.37 (0.53%) |
| Ex-dividend date | 02 May 2024 |
| 1y target est | N/A |
- Business Wire
VSE Corporation Prices Public Offering of Common Stock
ALEXANDRIA, Va., May 15, 2024--VSE Corporation ("VSE" or the "Company") (NASDAQ: VSEC), a leading provider of aftermarket distribution and repair services, announced today that it has priced its previously announced underwritten public offering of 2,112,676 shares of its common stock at a price to the public of $71.00 per share. VSE has also granted the underwriters a 30-day option to purchase up to an additional 316,901 shares of common stock. The offering is expected to close on May 17, 2024,
- Business Wire
VSE Corporation Announces Public Offering of Common Stock
ALEXANDRIA, Va., May 14, 2024--VSE Corporation ("VSE" or the "Company") (NASDAQ: VSEC), a leading provider of aftermarket distribution and repair services, announced today that it has commenced an underwritten public offering, subject to market and other conditions, of shares of its common stock pursuant to an effective shelf registration statement. In addition, VSE intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the
- GlobeNewswire
Anika Announces CFO Transition
Steve Griffin Appointed Chief Financial Officer, Effective June 3, 2024BEDFORD, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it has appointed Steve Griffin as the Company’s Executive Vice President, Chief Financial Officer (“CFO”) and Treasurer, effective June 3, 2024. He succeeds Michael Levitz, who has decided to step down as CFO after almost four years with the compa
